PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $490,551 | -66.3% | 47,488 | -57.2% | 0.00% | – |
| Q2 2023 | $1,455,040 | +207.9% | 110,987 | +162.6% | 0.00% | – |
| Q1 2023 | $472,534 | -14.7% | 42,266 | -35.6% | 0.00% | – |
| Q4 2022 | $553,648 | +150.5% | 65,676 | +337.5% | 0.00% | – |
| Q2 2022 | $221,000 | -94.8% | 15,011 | -91.2% | 0.00% | -100.0% |
| Q1 2022 | $4,227,000 | +153.0% | 170,353 | +227.0% | 0.00% | +100.0% |
| Q4 2021 | $1,671,000 | +623.4% | 52,100 | +711.8% | 0.00% | – |
| Q3 2021 | $231,000 | -91.8% | 6,418 | -90.0% | 0.00% | -100.0% |
| Q2 2021 | $2,824,000 | +782.5% | 64,000 | +813.9% | 0.00% | – |
| Q1 2021 | $320,000 | – | 7,003 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 815,019 | $37,279,000 | 40.66% |
| Yu Fan | 303,030 | $13,861,000 | 36.18% |
| ABG Innovation Capital Partners III GP Ltd | 833,333 | $38,117,000 | 18.73% |
| KPCB XIII Associates, LLC | 994,971 | $45,510,000 | 9.36% |
| Iron Triangle Partners LP | 600,000 | $27,444,000 | 3.49% |
| Miura Global Management | 405,000 | $18,525,000 | 3.31% |
| GREAT POINT PARTNERS LLC | 114,345 | $5,230,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 937,032 | $42,860,000 | 0.90% |
| ADAMS STREET PARTNERS LLC | 114,661 | $5,245,000 | 0.84% |
| RTW INVESTMENTS, LP | 1,129,600 | $51,668,000 | 0.81% |